These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3875165)

  • 1. [Acute-phase markers in gynecologic tumors].
    Tatra G
    Strahlentherapie; 1985 Aug; 161(8):487-91. PubMed ID: 3875165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative studies on the value of acute phase proteins and CA-125 for monitoring patients with ovarian cancer].
    Kölbl H; Tatra G; Schieder K; Bieglmayer C
    Strahlenther Onkol; 1988 Dec; 164(12):724-8. PubMed ID: 2462754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ceruloplasmin in the diagnosis of gynecologic tumors].
    Schultek T; Tode B; Wood WG
    J Clin Chem Clin Biochem; 1986 Mar; 24(3):179-84. PubMed ID: 3711801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
    Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of serum acute-phase reactants in patients with ovarian tumors.
    Warwas M; Dobryszycka W; Gerber J; Pietkiewicz A
    Neoplasma; 1981; 28(4):485-90. PubMed ID: 7290269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC)].
    Kasprzyk M; Dyszkiewicz W; Zwaruń D; Szydlik S; Leśniewska K; Krzyzanowski M
    Przegl Lek; 2006; 63(10):936-40. PubMed ID: 17288188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of squamous cell carcinoma antigen (SCC-A) in Egyptian gynecologic cancer patients.
    Salman T; el-Ahmady O; Tony O; Darwish M
    Anticancer Res; 1997; 17(4B):3083-6. PubMed ID: 9329607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
    Cole LA; Tanaka A; Kim GS; Park SY; Koh MW; Schwartz PE; Chambers JT; Nam JH
    Gynecol Oncol; 1996 Feb; 60(2):264-70. PubMed ID: 8631549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
    J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum haptoglobin and alpha-1 antitrysin levels as biological evolution markers in patients with gastric and colorectal cancer].
    Kovcić V; Jelić S; Filipović I; Tomasević Z
    Srp Arh Celok Lek; 1994; 122(11-12):311-3. PubMed ID: 17974404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Examination of acute phase proteins concentrations in children with allergic rhinitis].
    Steiner I; Sobieska M; Pucher B; Grzegorowski M; Samborski W
    Ann Acad Med Stetin; 2006; 52(2):33-7; discussion 37. PubMed ID: 17633124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasmafibronectin in case of tumors of the female genital system].
    Tatra G; Nasr F
    Strahlentherapie; 1983 Oct; 159(10):606-9. PubMed ID: 6417840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of alpha-1-antitrypsin in pancreatic islet cell tumors.
    Prinz RA; Sandberg L
    J Med; 1984; 15(3):177-83. PubMed ID: 6098624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM; Sauer-Eppel H; Bruzdziak TH
    Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer.
    Devine PL; McGuckin MA; Ramm LE; Harada H; Ward BG
    Cancer Biochem Biophys; 1993 Sep; 13(4):221-38. PubMed ID: 8521372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute phase reactants and clinical stages in multiple myeloma.
    San Miguel J; Vicente V; Battle J; Hernandez F; Lopez Borrasca A
    Neoplasma; 1981; 28(3):333-8. PubMed ID: 7290260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Haptoglobins in gynecologic tumors (author's transl)].
    Tatra G; Moser C
    Strahlentherapie; 1978 May; 154(5):323-7. PubMed ID: 418536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of escharectomy and skin grafting during early burn stage on acute-phase response in severely burned rats and its significance].
    Chai J; Wu Y; Sheng Z
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1420-3. PubMed ID: 12509927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
    J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.